{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:24:36Z","timestamp":1790447076630,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.dadr.2024.100240","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:10:18Z","timestamp":1716491418000},"page":"100240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Fentanyl, carfentanil and other fentanyl analogues in Canada\u2019s illicit opioid supply: A cross-sectional study"],"prefix":"10.1016","volume":"12","author":[{"given":"Robert A.","family":"Kleinman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2024.100240_bib1","unstructured":"British Columbia Coroner Service, n.d. Unregulated Drug Deaths - BC [WWW Document]. URL https:\/\/app.powerbi.com\/view?r=eyJrIjoiZGFlZWE2OWMtNGM1Zi00ZmIzLWI0N2UtN2ZiODE3YzVmMDg2IiwidCI6IjZmZGI1MjAwLTNkMGQtNGE4YS1iMDM2LWQzNjg1ZTM1OWFkYyJ9 (accessed 9.18.23)."},{"key":"10.1016\/j.dadr.2024.100240_bib2","series-title":"Methadone treatment for people who use fentanyl: recommendations","author":"Bromley","year":"2021"},{"key":"10.1016\/j.dadr.2024.100240_bib3","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6905a2","article-title":"Carfentanil Outbreak \u2014 Florida, 2016\u20132017","volume":"69","author":"Delcher","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.dadr.2024.100240_bib4","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.dadr.2024.100240_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000001007","article-title":"Buprenorphine Initiation in the Era of High-potency Synthetic Opioids: A Call for Community-based Participatory Research to Help Learning Health Systems Provide Precision Medicine for Opioid Use Disorder","volume":"16","author":"Fiellin","year":"2022","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.dadr.2024.100240_bib6","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/add.15862","article-title":"Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort study","volume":"117","author":"Gomes","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2024.100240_bib7","series-title":"Spotlight: The evolution of Fentanyl in Canada over the past 11 years","author":"Government of Canada","year":"2023"},{"key":"10.1016\/j.dadr.2024.100240_bib8","unstructured":"Health Canada, 2023. Drug Analysis Service [WWW Document]. URL https:\/\/www.canada.ca\/en\/health-canada\/services\/health-concerns\/controlled-substances-precursor-chemicals\/drug-analysis-service.html (accessed 8.16.23)."},{"key":"10.1016\/j.dadr.2024.100240_bib9","article-title":"Fentanyl concentration in drug checking samples and risk of overdose death in Vancouver, Canada","author":"Kennedy","year":"2023","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.dadr.2024.100240_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/CXA.0000000000000169","article-title":"Suggestions for Canada\u2019s opioid use disorder management guidelines","volume":"14","author":"Kleinman","year":"2023","journal-title":"Can. J. Addict."},{"key":"10.1016\/j.dadr.2024.100240_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071467","article-title":"Is daily supervised buprenorphine-naloxone necessary?","author":"Kleinman","year":"2022","journal-title":"BMJ 378"},{"key":"10.1016\/j.dadr.2024.100240_bib12","doi-asserted-by":"crossref","first-page":"E1718","DOI":"10.1503\/cmaj.230968","article-title":"Using short-acting opioids to relieve opioid withdrawal in hospital","volume":"195","author":"Kleinman","year":"2023","journal-title":"CMAJ"},{"key":"10.1016\/j.dadr.2024.100240_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.7326\/M21-3968","article-title":"Treating opioid withdrawal in the hospital: a role for short-acting opioids","volume":"175","author":"Kleinman","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.dadr.2024.100240_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamapsychiatry.2021.3292","article-title":"Insights Into mixing fentanyl and benzodiazepines from Canadian drug seizures","volume":"79","author":"Pardo","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.dadr.2024.100240_bib15","doi-asserted-by":"crossref","first-page":"m772","DOI":"10.1136\/bmj.m772","article-title":"Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study","author":"Pearce","year":"2020","journal-title":"BMJ 368"},{"key":"10.1016\/j.dadr.2024.100240_bib16","unstructured":"Public Health Agency of Canada, 2023. Opioid- and Stimulant-related Harms in Canada [WWW Document]. URL https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/ (accessed 11.29.23)."},{"key":"10.1016\/j.dadr.2024.100240_bib17","unstructured":"Public Health Ontario, 2023. Interactive Opioid Tool [WWW Document]. URL https:\/\/www.publichealthontario.ca\/en\/Data-and-Analysis\/Substance-Use\/Interactive-Opioid-Tool#\/ (accessed 6.17.23)."},{"key":"10.1016\/j.dadr.2024.100240_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12954-021-00585-2","article-title":"Diverse psychotropic substances detected in drug and drug administration equipment samples submitted to drug checking services in Toronto, Ontario, Canada, October 2019\u2013April 2020","volume":"19","author":"Scarfone","year":"2022","journal-title":"Harm. Reduct. J."},{"key":"10.1016\/j.dadr.2024.100240_bib19","article-title":"Drug Overdose Deaths in the United States, 2001\u20132021","author":"Spencer","year":"2022","journal-title":"NCHS Data Brief."},{"key":"10.1016\/j.dadr.2024.100240_bib20","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1111\/add.15893","article-title":"Opioid withdrawal management in the fentanyl era","volume":"117","author":"Thakrar","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2024.100240_bib21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/aje\/kwab129","article-title":"Time-Series Analysis of Fentanyl Concentration in the Unregulated Opioid Drug Supply in a Canadian Setting","volume":"191","author":"Tobias","year":"2022","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.dadr.2024.100240_bib22","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/ADM.0000000000001202","article-title":"ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids","volume":"17","author":"Weimer","year":"2023","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.dadr.2024.100240_bib23","article-title":"Associations between opioid overdose deaths and drugs confiscated by law enforcement and submitted to crime laboratories for analysis, United States, 2014\u20132019: an observational study","volume":"25","author":"Zibbell","year":"2023","journal-title":"Lancet Reg. Health - Am."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T22:04:35Z","timestamp":1732053875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724624000246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":23,"alternative-id":["S2772724624000246"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100240","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fentanyl, carfentanil and other fentanyl analogues in Canada\u2019s illicit opioid supply: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100240"}}